Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 219 results found. Search for [ Moderna ]

Results 1 to 21 of 219
Reuters
September 22, 2020
Asked which drugmaker could be approved, Trump told Fox News in an interview: \"Pfizer's doing really well,\" adding \"Johnson & Johnson ... they'll probably be a little later.\"


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


Reuters
September 16, 2020
In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


BusinessToday.In
September 9, 2020
AstraZeneca said in a statement that its COVID-19 vaccine candidate's trials have been halted, not stopped, as it is going to conduct a review of safety data by an independent committee


Associated Press
September 9, 2020
Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain


BusinessToday.In
September 5, 2020
A group of pharma companies are reportedly planning to stand together against the release of any coronavirus vaccine till all safety protocols are complete


BusinessToday.In
September 4, 2020
Coronavirus vaccine update: Even as drugmakers worldwide race against time, the final data on whether a vaccine can prevent people from getting infected will only come by the middle of September


Associated Press
September 2, 2020
That cooperative effort, linked with the WHO, would allow nations to take advantage of a portfolio of potential vaccines to ensure their citizens are quickly covered by whichever ones are deemed effective


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


BusinessToday.In
September 1, 2020
Coronavirus vaccine update: AstraZeneca is one of the leading contenders in the race to develop coronavirus vaccine


Reuters
September 1, 2020
Canada's two agreements follow separate deals with Pfizer Inc and Moderna Inc announced weeks ago, and are the latest example of countries rushing to secure access to vaccines


BusinessToday.In
New Delhi, August 27, 2020
Alibaba, which has fuelled the growth of several Indian start-ups, will not put in fresh funds to expand its investments in India for at least six months; Apple will launch its first online store in India in September; The government will sell up to 15 per cent stake in Hindustan Aeronautics (HAL) through an offer for sale (OFS), which could fetch about Rs 5,000 crore to the exchequer. Watch this and more news on News Blast.


BusinessToday.In
New Delhi, August 27, 2020
Moderna COVID-19 vaccine appears to work as well in older adults in early studyModerna Inc has said its experimental COVID-19 vaccine induced immune responses in older adults similar to those in younger participants. This offers hope that it will be effective in people considered to be at high risk for severe complications from the coronavirus. The company is one of the leading contenders in the race to develop a vaccine against the virus Alibaba puts India investment plans on hold due to C...


BusinessToday.In
August 27, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by HDFC twins, SBI, M&M, ICICI Bank, Axis Bank, ITC and Asian Paints were among the top gainers in the Sensex pack. On the other hand, Bajaj Auto, Bajaj Finance, HUL and NTPC were among the laggards


Reuters
August 27, 2020
Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines


BusinessToday.In
August 25, 2020
Coronavirus vaccine news update: Russian Ambassador Nikolai Kudashev reached out to India on Tuesday seeking a partnership in the production of coronaviru vaccine Sputnik V


PAGES 1 OF 11  12345